DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

MS Contin (Morphine) - Confusional State - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Confusional State (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to MS Contin (Morphine) where reactions include confusional state. The selected reports were submitted to the FDA during the sample period of about a year.

Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 39 year old male

Reported by a consumer/non-health professional from Canada on 2012-06-08

Patient: 39 year old male

Reactions: Speech Disorder, Confusional State, Hyperaesthesia, Pain, Drug Withdrawal Syndrome, Drug Dependence, Somnolence, Tremor

Drug(s) suspected as cause:
Morphine Sulfate
    Dosage: 5 mg, unk
    Indication: Pain

MS Contin
    Indication: Pain

Morphine Sulfate
    Indication: Pain

Morphine Sulfate
    Dosage: 500 mg, daily

Other drugs received by patient: Opium / Naloxone TAB



Possible MS Contin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: female

Reactions: Confusional State, Incorrect Dose Administered, Gait Disturbance, Hallucination, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 30 mg, 2x/day
    Administration route: Oral

Revlimid
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-08-24

Other drugs received by patient: Neurontin; Percocet



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-04-16

Patient: male

Reactions: Confusional State, Prostate Cancer Metastatic, Multiple Drug Overdose, Respiratory Depression, Drug Abuse

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01

Morphine Sulfate
    Dosage: 30 mg, every 4-6 hours as needed
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-04-11

Patient: male

Reactions: Confusional State, Prostate Cancer Metastatic, Respiratory Depression, Multiple Drug Overdose, Drug Abuse

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01

Morphine Sulfate
    Dosage: 30 mg, q4- 6h prn
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-12

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 53 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-01

Patient: 53 year old female

Reactions: Neurotoxicity, Myoclonus, Confusional State, Drug Effect Decreased, Sedation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fentanyl
    Indication: Pain

Fentanyl

Hydromorphone HCL

Morphine
    Administration route: Oral
    Indication: Pain

MS Contin
    Administration route: Oral

Morphine
    Administration route: Oral

Fentanyl

Fentanyl

Methadone Hydrochloride
    Administration route: Oral
    Indication: Pain

MS Contin
    Administration route: Oral
    Indication: Pain

Methadone Hydrochloride
    Administration route: Oral

Hydromorphone HCL
    Indication: Pain

Hydromorphone HCL



Possible MS Contin side effects in 83 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-11-28

Patient: 83 year old male

Reactions: Confusional State, Vomiting, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin

Other drugs received by patient: Temesta / 00273201 /; Irbesartan



Possible MS Contin side effects in 53 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-16

Patient: 53 year old female

Reactions: Confusional State, Neurotoxicity, Myoclonus, Drug Effect Decreased, Sedation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Indication: Pain

Methadone HCL
    Administration route: Oral

MS Contin

Methadone HCL
    Administration route: Oral
    Indication: Pain

Hydromorphone HCL
    Indication: Pain

Fentanyl
    Indication: Pain

Hydromorphone HCL

Morphine
    Administration route: Oral

Fentanyl

Fentanyl

Hydromorphone HCL

Fentanyl

Morphine
    Administration route: Oral
    Indication: Pain



Possible MS Contin side effects in 53 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24

Patient: 53 year old female

Reactions: Confusional State, Myoclonus, Neurotoxicity, Drug Effect Decreased, Sedation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Morphine
    Administration route: Oral
    Indication: Pain

Hydromorphone HCL
    Administration route: Oral

Hydromorphone HCL
    Administration route: Oral

Fentanyl

Hydromorphone HCL
    Administration route: Oral
    Indication: Pain

MS Contin

Fentanyl
    Indication: Pain

Fentanyl

Fentanyl

MS Contin
    Indication: Pain

Morphine
    Administration route: Oral

Methadone HCL
    Administration route: Oral

Methadone HCL
    Administration route: Oral
    Indication: Pain



Possible MS Contin side effects in 39 year old male

Reported by a physician from United States on 2011-10-10

Patient: 39 year old male

Reactions: Weight Decreased, Confusional State, Bile Duct Obstruction, Drug Effect Decreased, Dysphagia, Anaemia, Hypotension, General Physical Health Deterioration, Neoplasm Progression, Somnolence, Malaise, Cholangitis, Urinary Retention, Hallucination, Muscle Spasms

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Exalgo
    Dosage: 32 mg, unk
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Morphine
    Dosage: 20 mg, single
    Indication: Pain
    Start date: 2010-01-01
    End date: 2010-01-01

Fentanyl-100
    Dosage: 125 ug/hr, unk
    Start date: 2010-06-01
    End date: 2010-01-01

Fentanyl-100
    Dosage: 150 ug/hr, unk
    Start date: 2010-01-01

Fentanyl-100
    Dosage: 200 ug/hr, unk
    Start date: 2010-01-01
    End date: 2010-01-01

Gemcitabine Hydrochloride
    Dosage: 3 series of 8 treatments
    Indication: Chemotherapy
    Start date: 2010-04-01
    End date: 2010-07-01

Nsaid's
    Dosage: prn pain
    Indication: Pain

FEM Protocol
    Dosage: 2 series
    Start date: 2010-01-01

Fentanyl-100
    Dosage: 50 ug/hr, unk
    Indication: Cancer Pain

Fentanyl-100
    Dosage: unk
    Start date: 2010-01-01
    End date: 2010-01-01

Fentanyl-100
    Dosage: 100 ug/hr, unk
    Start date: 2010-01-01
    End date: 2010-01-01

Nsaid's
    Dosage: regularly administered

Cisplatin
    Dosage: 3 series of 8 treatments
    Indication: Chemotherapy
    Start date: 2010-04-01
    End date: 2010-07-01

MS Contin
    Dosage: 3 x130 mg
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2010-10-01

Fentanyl-100
    Dosage: 75 ug/hr, unk
    End date: 2010-04-01

Fentanyl-100
    Dosage: 250 ug/hr, unk
    Start date: 2010-01-01
    End date: 2010-10-01

MS Contin
    Dosage: 3 x 190 mg
    Administration route: Oral
    End date: 2010-01-01

MS Contin
    Dosage: 2 x 90 mg
    Administration route: Oral
    Start date: 2010-01-01

Morphine Sulfate
    Dosage: unk
    Indication: Breakthrough Pain
    Start date: 2010-01-01

Amitriptyline HCL
    Dosage: 2 x 1
    Indication: Pain

Other drugs received by patient: Proton Pump Inhibitors

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017